J026-2371 Screening compound: methyl 1-(3-methoxyphenyl)-7-methyl-3-[2-(4-methylpiperidino)-2-oxoethyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylate

J026-2371 Screening compound: methyl 1-(3-methoxyphenyl)-7-methyl-3-[2-(4-methylpiperidino)-2-oxoethyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylate
J026-2371 Screening compound: methyl 1-(3-methoxyphenyl)-7-methyl-3-[2-(4-methylpiperidino)-2-oxoethyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound J026-2371
methyl 1-(3-methoxyphenyl)-7-methyl-3-[2-(4-methylpiperidino)-2-oxoethyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J026-2371

Molecular Formula

C25H28N4O6 (C25 H28 N4 O6)

Compound Name

methyl 1-(3-methoxyphenyl)-7-methyl-3-[2-(4-methylpiperidino)-2-oxoethyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylate

IUPAC name

methyl 1-(3-methoxyphenyl)-7-methyl-3-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-24-dioxo-1H2H3H4H-pyrido[23-d]pyrimidine-5-carboxylate

SMILES

CC(CC1)CCN1C(CN(C(c(c(N1c2cc(OC)ccc2)nc(C)c2)c2C(OC)=O)=O)C1=O)=O

InChI

InChI=1S/C25H28N4O6/c1-15-8-10-27(11-9-15)20(30)14-28-23(31)21-19(24(32)35-4)12-16(2)26-22(21)29(25(28)33)17-6-5-7-18(13-17)34-3/h5-7,12-13,15H,8-11,14H2,1-4H3

InChI Key

QIVFIBIOHUXHCR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27219752

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.52

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.891

Distribution Coefficient, logD

2.891

Water Solubility, LogSw

-3.14

Polar Surface Area

85.471

Acid Dissociation Constant (pKa)

22.46

Base Dissociation Constant (pKb)

2.21

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

J026-2371 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with J026-2371 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J026-2371?
Check Price and Availability of J026-2371, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J026-2371 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J026-2371
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J026-2371
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J026-2371 available by request